Ongoing Clinical Trials
Ongoing clinical trials include:
SUSTAIN: A Phase II Study to Assess Safety and Efficacy of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises
An open-label clinical trial to assess the safety and efficacy of macitentan for treatment of pre-capillary pulmonary hypertension in sickle cell disease
Multicenter Registry of Sickle Cell Disease Patients
Biomarker studies of sickle cell disease patients during vasoocclusive events
Recently completed clinical trials include:
- Neurocognitive studies of sickle cell disease patients
- Arginine in sickle cell anemia
- Use of P-selectin blockers in sickle cell anemia